Clinical Trials on Bacterial Contamination in United Kingdom

Total 5807 results

Denver Health and Hospital Authority
University of Colorado, Denver

Completed

Bacterial Contamination of Healthcare Worker Uniforms

Bacterial Contamination of Healthcare Worker Uniforms

United States
Pediatrix

Completed

Surveillance Study of Bacterial Contamination of the Parent's Cell Phone in the NICU

Bacterial Contamination Rate of the Cell Phones

United States
Denver Health and Hospital Authority

Completed

Bacterial Contamination of Workwear

Bacterial Contamination of Physician Attire

United States
Travis Callahan

Completed

EPIC: Effect of Povidone Iodine Periurethral Cleansing on Level of Contamination With Clean Catch

Urine Contamination

United States
Kimberly-Clark Corporation

Completed

Study of the Combination of a Cyanoacrylate and Surgical Solutions in Reducing Skin Flora Contamination

Skin Flora Contamination

United States, Chile, Brazil, Germany, Singapore
Prescient Surgical

Completed

Cleancision IntRaoperative Contamination prEvention Study (CIRCE)

Colorectal Surgery | Wound Contamination

United States
Orthopaedic Education and Research Institute (dba...
Irrimax Corporation

Recruiting

Wound Irrigation Comparative Effectiveness Study

Cutibacterium Acnes Contamination

United States
Imperial College London

Recruiting

Addition of Probenecid to Penicillin-V Therapy (ADDPROPEN)

Infection, Bacterial

United Kingdom
Guy's and St Thomas' NHS Foundation Trust

Unknown

Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread

Gram-Negative Bacterial Infections

United Kingdom
Danisco
Community Pharmacology Services Ltd

Completed

PreFem: "What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?" (PreFem)

Bacterial Vaginosis

United Kingdom
Forest Laboratories

Completed

Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy

Helicobacter Infections

United Kingdom
Imperial College London
Hammersmith Hospitals NHS Trust

Completed

Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections

Staphylococcal Infections | Gram-positive Bacterial Infections

United Kingdom
Destiny Pharma Plc

Completed

Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)

Staphylococcal Infection

United Kingdom
University of Oxford

Completed

A Study to Quantify Bacille Calmette Guerin (BCG) and Characterise the Immune Response After BCG Vaccination

Tuberculosis

United Kingdom
Barts & The London NHS Trust
Imperial College London; Wellcome Trust; University of Cape Town; Newham Chest... and other collaborators

Completed

Effects of Vitamin D Supplementation on Antimycobacterial Immunity

Tuberculosis

United Kingdom
St George's, University of London
University of Nottingham; Medical Research Council; Public Health England

Recruiting

Development of a Serocorrelate of Protection Against Invasive Group B Streptococcus Disease (iGBS3)

Streptococcus Agalactiae Infection

United Kingdom
University of Edinburgh
NHS Lothian

Completed

Virtual Observed Therapy for Patients With Tuberculosis

Tuberculosis

United Kingdom
St George's Healthcare NHS Trust

Unknown

Genome Sequencing of Multidrug Resistant Tuberculosis (MDR TB) in Sputum (MDRTB01)

Tuberculosis

United Kingdom
Niso Biomed S.R.L.

Unknown

Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy

Helicobacter Infections

United Kingdom
University of Oxford

Completed

Safety of Tuberculosis Vaccine, MVA85A, Administered by the Intramuscular Route and the Intradermal Route

Tuberculosis

United Kingdom
GlaxoSmithKline

Completed

First Time in Human (FTIH) Safety and Pharmacokinetics (PK) Study of GSK3036656 in Healthy Subjects

Tuberculosis

United Kingdom
Destiny Pharma Plc

Completed

Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects

Staphylococcus Aureus Infection

United Kingdom
University of Oxford

Completed

A Phase I Study to Assess the Safety and Immunogenicity of Tuberculosis (TB) Vaccine Candidates FP85A and MVA85A

Tuberculosis

United Kingdom
Barts & The London NHS Trust
NHS Research and Development

Unknown

Can Screening People Registering With Primary Care Improve the Detection of Tuberculosis?

Tuberculosis

United Kingdom
Stuart Bond

Active, not recruiting

ElastoMeric Infusion Pumps for Hospital AntibioTICs (EMPHATIC)

Infection, Bacterial

United Kingdom
St George's, University of London
King's College London; Statens Serum Institut

Not yet recruiting

The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study (LISA)

Bacterial Vaginosis | Candida Vaginal

United Kingdom
University of Southampton
University Hospital Southampton NHS Foundation Trust

Unknown

A Controlled Study to Assess Safety, Colonisation and Immunogenicity of Reconstituted Lyophilised Neisseria Lactamica (Lac5-Nasal)

Meningitis, Bacterial

United Kingdom
University of Southampton
University Hospital Southampton NHS Foundation Trust

Completed

Defining the Immune Response to Nasopharyngeal Colonisation by the Commensal Neisseria Lactamica (Lac-7)

Meningitis, Bacterial

United Kingdom
Statens Serum Institut
Imperial College London

Completed

Safety and Immunogenicity of a Chlamydia Vaccine CTH522 (CHLM-02)

Trachoma

United Kingdom
MJM Bonten
Paris 12 Val de Marne University

Completed

Ecological Effects of Decolonisation Strategies in Intensive Care (RGNOSIS)

ICU-ecology (Multidrug Resistant Bacteria) | ICU-acquired Bacteraemia

Belgium, Spain, United Kingdom, Italy, Portugal, Slovenia
Nabi Biopharmaceuticals
Public Health England

Completed

StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery

Staphylococcal Infections

United Kingdom
Liverpool School of Tropical Medicine
University of Oxford

Recruiting

Using BCG Vaccine to Understand Tuberculosis Infection (Pilot BCG CHIM)

Tuberculosis

United Kingdom
University of Oxford
Mason Medical Research Trust

Completed

Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines

Pneumococcal Disease

United Kingdom
University of Southampton
University Hospital Southampton NHS Foundation Trust

Completed

Challenge of the Nasopharynx With Neisseria Lactamica Expressing the Meningococcal Protein Neisseria Adhesin A (NadA) (NadA-Lac4)

Meningitis, Bacterial | Neisseria Infection

United Kingdom
Novartis Vaccines

Completed

Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Same Vaccine

Meningococcal Disease

United Kingdom
Novartis Vaccines

Completed

Safety, Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine, When Administered to Healthy Infants

Meningococcal Disease

United Kingdom
Novartis Vaccines

Completed

Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same Vaccine

Meningococcal Disease

United Kingdom
Public Health England

Completed

A Study to Gather Safety Data Following Administration of a Hib-containing Booster Vaccine in Children Aged Two to Five Years (DIPS)

Haemophilus Infections

United Kingdom
Belfast Health and Social Care Trust

Completed

Procalcitonin in Diagnosis of Bacterial Infections in Young Infants

Sepsis

United Kingdom
St George's, University of London

Unknown

Innovative Reagents for Improving Rapid Diagnosis of Mycobacterial Infections (TIKA_TB)

Tuberculosis (TB)

United Kingdom
Helen Reynolds
Liverpool University Hospitals NHS Foundation Trust

Completed

The Effect of Intermittent Rifampicin on Raltegravir (RIFRAL)

HIV | Tuberculosis

United Kingdom
University of Oxford

Completed

A BCG Challenge Model Study to Assess Anti-mycobacterial Immunity Induced by BCG and a Candidate TB Vaccine, MVA85A

Tuberculosis

United Kingdom
University of Oxford
Wellcome Trust; St George's, University of London

Completed

T-Cell Turnover Following Vaccination With MVA85A

Tuberculosis

United Kingdom
University of Oxford

Completed

Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.

Tuberculosis

United Kingdom
University of Oxford

Completed

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously

Tuberculosis

United Kingdom
University of Oxford

Completed

The Microbiology of Pleural Infection (TORPIDS)

Pleural Infection | Pleural Infection Bacterial

United Kingdom
University College, London
Public Health England

Completed

Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection (NextGen)

Tuberculosis

United Kingdom
Queen Mary University of London
University College, London; Public Health England

Completed

Completion and Acceptability of Treatment Across Primary Care and the commUnity for Latent Tuberculosis (CATAPULT)

Latent Tuberculosis

United Kingdom
University Hospital Southampton NHS Foundation...
University of Southampton

Unknown

A Study Assessing Colonisation & Immunogenicity After Nasal Inoculation With N. Lactamica and Eradication on Day 4 or 14 (Lac-3)

Meningitis, Meningococcal

United Kingdom
University of Oxford

Completed

A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG

Tuberculosis

United Kingdom

Clinical Trials on Bacterial Contamination in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations